•  
  •  
  •  
  •  

2025-10-01 15:36:27

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • CFF Fluid Control Ltd receives LOI worth Rs. 27.74 crores
  • Indegene announces acquisition of BioPharm to Expand AI-Driven Marketing and AdTech for Global Pharma
  • Goodluck India Ltd enters into Strategic Alliance with BrahMos Aerospace Thiruvananthapuram Ltd and Axiscades Technologies Ltd to Bid for AMCA's Indigenous Manufacturing
  • IRIS Business Services Ltd receives contract in Qatar
  • Kirloskar Brothers Ltd receives order for pump sets from IOCL

Keywords Selected:  USMarket

Market Commentary

  • Pre-Market - Dec 13, 2022 - Reliance Securities
  • Weekly Report - Nov 19, 2022 - Reliance Securities
  • Tech stocks remain investor favorites in US market, Index ETFs gaining traction among Indian investors: Vested Finance

Stock Report

  • Scorpius Trackers Inc. Launches in the USA, Targets 2,000 MW Annual Supply by 2028
  • STL introduces Optical Connectivity portfolio for the US market
  • Dr. Reddy's Laboratories announces the launch of Doxycycline Capsules, 40 mg* in the U.S.
  • Shilpa Medicare updates on launch of Pemetrexed Injection, 100mg/10 ml, 500 mg/50 ml, 1000 mg/100 ml
  • Wardwizard Foods and Beverages Ltd embarks on US Market Expansion, Secures USFDA Registration
  • Zydus and Synthon enter into an exclusive licensing and supply agreement for Palbociclib Tablets for the US market
  • Responsive Industries Introduces 'Artisan Edge'
  • Dr. Reddy's Laboratories announces the launch of Regadenoson Injection 0.4 mg/5 mL in the U.S.
  • Dr. Reddy's Laboratories announces the launch of Treprostinil Injection in the U.S.
  • Dr. Reddy's Laboratories launches Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market
  • Glenmark Pharmaceuticals Ltd updates on Baddi facility
  • Dr. Reddy's Labs launches Fesoterodine Fumarate Extended-Release Tablets in the U.S. market
  • NATCO announces Launch of First Generic Version of Nexavar® (Sorafenib) Tablets in the U.S. Market
  • Bortezomib for Injection, 3.5 mg/vial, Single-Dose Vial launched in the US Market
  • Lupin Launches Merzee® Capsules in the United States
  • izmo launches new product - izmoEmporio - in the US
  • BEL signs USD 73 Million contract with Hyperion Global Group LLC, USA, for supply of IoT devices to the US
  • Dr. Reddy's Laboratories announces the launch of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial in the U.S. Market

Latest Post

  • CFF Fluid Control Ltd receives LOI worth Rs. 27.74 crores
  • Indegene announces acquisition of BioPharm to Expand AI-Driven Marketing and AdTech for Global Pharma
  • Goodluck India Ltd enters into Strategic Alliance with BrahMos Aerospace Thiruvananthapuram Ltd and Axiscades Technologies Ltd to Bid for AMCA's Indigenous Manufacturing
  • IRIS Business Services Ltd receives contract in Qatar
  • Kirloskar Brothers Ltd receives order for pump sets from IOCL


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024